Bioteque Corporation (4107.TWO)
- Previous Close
123.00 - Open
124.50 - Bid 123.50 x --
- Ask 124.50 x --
- Day's Range
122.50 - 124.50 - 52 Week Range
102.00 - 128.00 - Volume
93,248 - Avg. Volume
219,872 - Market Cap (intraday)
8.558B - Beta (5Y Monthly) 0.44
- PE Ratio (TTM)
19.00 - EPS (TTM)
6.50 - Earnings Date May 9, 2024 - May 24, 2024
- Forward Dividend & Yield 4.50 (3.64%)
- Ex-Dividend Date Aug 30, 2023
- 1y Target Est
--
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It also offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine collection bags; and IV administration products, such as PVC IV infusion bags, PVC bags, and twist-off ports. In addition, the company provides respiratory care products, such as closed suction catheters and endotracheal tubes; vascular access products comprising angiographic catheters, PTA balloon dilatation catheters, sheath introducers, guidewires, high pressure connecting tubes, PTCA balloon dilatation catheter-rapid exchange products, manifolds, and Y connectors; and medical components, including dialyzer connectors and caps, recirculating connectors with cap, rotating luer lock connectors, pump and T connectors, female luers, injection sites, luer lock and chamber caps, drip chambers, filters, clamps, pressure pillows, safeline HDF components, chamber assembly, and transducer protectors, as well as medical masks. Bioteque Corporation was incorporated in 1991 and is headquartered in Taipei, Taiwan.
www.bioteq.com.twRelated News
Performance Overview: 4107.TWO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4107.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4107.TWO
Valuation Measures
Market Cap
8.56B
Enterprise Value
7.89B
Trailing P/E
19.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.42
Price/Book (mrq)
2.68
Enterprise Value/Revenue
4.06
Enterprise Value/EBITDA
10.70
Financial Highlights
Profitability and Income Statement
Profit Margin
23.27%
Return on Assets (ttm)
7.97%
Return on Equity (ttm)
14.55%
Revenue (ttm)
1.94B
Net Income Avi to Common (ttm)
452.55M
Diluted EPS (ttm)
6.50
Balance Sheet and Cash Flow
Total Cash (mrq)
1.56B
Total Debt/Equity (mrq)
28.04%
Levered Free Cash Flow (ttm)
459.47M
Research Analysis: 4107.TWO
Company Insights: 4107.TWO
4107.TWO does not have Company Insights